Recombinant Human B7-1/CD80 His-tag Avi-tag Protein, CF

Name: Recombinant Human B7-1/CD80 His-tag Avi-tag Protein, CF
Brand: R&D Systems
SKU: AVI9050
Price: 592 USD
Availability: InStock

R&D Systems | Catalog # AVI9050

Submit a review

Product Documents

Biotinylated

100% Guarantee

Product Specifications
Scientific Data
Preparation & Storage
Calculators
Background
Product Documents
Specific Notices
Research Areas

Key Product Details

R&D Systems CHO-derived Recombinant Human B7-1/CD80 His-tag Avi-tag Protein (AVI9050)
Quality control testing to verify active proteins with lot specific assays by in-house scientists
All R&D Systems proteins are covered with a 100% guarantee

Source

CHO

Accession Number

P33681-1

Conjugate

Biotin

Applications

Bioactivity

View all B7-1/CD80 Proteins and Enzymes »

Why choose R&D Systems Avi-tag B7-1 Protein?

Guaranteed Bioactivity and High Purity: Bioactivity tested by functional ELISA and purity determined by SDS-PAGE to be greater than 95%.
Lot-to-Lot Consistency: Stringent QC testing performed on each lot to ensure consistent activity and purity.
Bulk Quantities Available: Bulk up and save with large mass quantities to meet your research needs. Supply agreements available, partner with us. Please contact us.
Most Respected, Most Cited Brand in Proteins: With over 35 years of providing the best recombinant proteins to the scientific community, R&D Systems continues to lead the industry in quality, activity, and purity.

Find the Fc Chimera Avi-tag B7-1 protein here Fc Chimera Avi-tag B7-1 Protein

Product Specifications

Source

Chinese Hamster Ovary cell line, CHO-derived human B7-1/CD80 protein

Human B7-1/CD80 (Val35-Asn242) Accession # P33681-1	HHHHHH	Avi-tag
N-terminus		C-terminus

Purity

>95%, by SDS-PAGE visualized with Silver Staining and quantitative densitometry by Coomassie® Blue Staining.

Endotoxin Level

<0.10 EU per 1 μg of the protein by the LAL method.

N-terminal Sequence Analysis

Val35

Predicted Molecular Mass

25 kDa

SDS-PAGE

48-60 kDa

Activity

Measured by its binding ability in a functional ELISA.
When Recombinant Human CTLA‑4 Fc Chimera (Catalog # 7268-CT) is immobilized at 1 µg/mL (100 µL/well), Biotinylated Recombinant Human B7‑1/CD80 His-tag Avi-tag (Catalog # AVI9050) binds with an ED₅₀ of 0.1-0.6 μg/mL.

Scientific Data Images for Recombinant Human B7-1/CD80 His-tag Avi-tag Protein, CF

Recombinant Human B7-1/CD80 His-tag Avi-tag Protein Binding Activity

When Recombinant Human CTLA-4 Fc Chimera (Catalog # 7268-CT) is immobilized at 1 µg/mL, Biotinylated Recombinant Human B7-1/CD80 His-tag Avi-tag protein (Catalog # AVI9050) binds with an ED₅₀ of 0.1-0.6 µg/mL.

Recombinant Human B7-1/CD80 His-tag Avi-tag Protein SDS-PAGE

2 μg/lane of Biotinylated Recombinant Human B7-1/CD80 His-Tag Avi-tag (Catalog # AVI9050) was resolved with SDS-PAGE under reducing (R) and non-reducing (NR) conditions and visualized by Coomassie® Blue staining, showing bands at 48-60 kDa.

Formulation, Preparation, and Storage

AVI9050

Formulation	Lyophilized from a 0.2 μm filtered solution in PBS with Trehalose.
Reconstitution	Reconstitute at 500 μg/mL in PBS.
Shipping	The product is shipped at ambient temperature. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.

Calculators

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

Volume (to add to vial)

Mass (in vial)

Desired Reconstitution Concentration

Background: B7-1/CD80

B7-1/CD80 and B7-2/CD86, together with their receptors CD28 and CTLA-4, constitute one of the dominant co-stimulatory pathways that regulate T- and B-cell responses (1). Although both CTLA-4 and CD28 can bind to the same ligands, CTLA-4 binds to B7-1 and B7-2 with a 20-100 fold higher affinity than CD28 and is involved in the down-regulation of the immune response (2-6). Mature human B7-1 consists of a 208 aa extracellular domain (ECD) with two immunoglobulin-like domains, a 21 aa transmembrane domain, and a 25 aa cytoplasmic domain (7). Within the ECD, human B7-1 shares 50% aa sequence identity with mouse and rat
B7-1. Alternative splicing generates a 30 kDa soluble isoform that lacks the transmembrane segment and retains the ability to bind CD28 and CTLA-4 and an isoform that lacks the second Ig-like domain and the transmembrane segment (8). Both human and mouse B7-1 and B7-2 can bind to either human or mouse CD28 and
CTLA-4 (1). B7-1 is expressed on activated B cells, activated T cells, and macrophages. B7-2 is constitutively expressed on interdigitating dendritic cells, Langerhans cells, peripheral blood dendritic cells, memory B cells, and germinal center B cells (2).